Detalhe da pesquisa
1.
Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 68(9): e29123, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34061452
2.
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy.
Blood
; 128(3): 360-70, 2016 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27166358
3.
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1.
Transplant Cell Ther
; 27(6): 490.e1-490.e8, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33823167
4.
Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.
Blood
; 111(6): 3276-85, 2008 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17925486
5.
Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants.
J Pediatr Hematol Oncol
; 25(12): 934-40, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14663275